1. OMICS Group Contact us at: contact.omics@omicsonline.org OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group hosts over 400 leading-edge peer reviewed Open Access Journals and organizes over 300 International Conferences annually all over the world. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities that ensure a rapid, quality and quick review process. OMICS Group signed an agreement with more than 1000 International Societies to make healthcare information Open Access.

2. OMICS Group welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible way. OMICS Journals are poised in excellence by publishing high quality research. OMICS Group follows an Editorial Manager® System peer review process and boasts of a strong and active editorial board. Editors and reviewers are experts in their field and provide anonymous, unbiased and detailed reviews of all submissions. The journal gives the options of multiple language translations for all the articles and all archived articles are available in HTML, XML, PDF and audio formats. Also, all the published articles are archived in repositories and indexing services like DOAJ, CAS, Google Scholar, Scientific Commons, Index Copernicus, EBSCO, HINARI and GALE. For more details please visit our website: http://omicsonline.org/Submitmanuscript.php http://omicsonline.org/Submitmanuscript.php OMICS Journals are welcoming Submissions

3. EB PPT

4. PhD in Pharmaceutical Technology and degree in Pharmaceutical Sciences, University of Porto, Portugal; Affiliated Researcher at Institute of Biomedical Engineering (INEB), Porto, Portugal; Assistant Professor of Pharmaceutical and Biopharmaceutical Technology at ISCS-N, Gandra, Portugal. His current research is focused on the study of nanomedicines e.g., polymer-based nanoparticles, solid lipid nanoparticles and polymeric micelles, and their application in the pharmaceutical and biomedical fields, as well as on the use of in vitro cell models as a tool to correlate the transport of biopharmaceuticals and nanoparticles across human intestinal mucosa. He is internationally recognised has an expert on oral delivery of biopharmaceuticals through nanomedicines. In this field he authors several publications, some are key references in the area, being pioneer of polymeric and solid lipid nanoparticles for intestinal delivery of insulin. His work has been successful, with more than 100 publications in less than 8, 3 edited books in the field of Pharmaceutical Technology and Nanomedicine, 26 book chapters and more than 150 conference proceedings/abstracts and serves as editorial board member of several international journals and evaluator of research projects form international agencies. Further is work as research scientist in various research projects and Professor, he is also supervisor of many PhD (18), postdoctoral (4) and master students (more than 15). He is also an active member of several international associations (AAPS, CRS, EUFEPS, EFSD, FIP, BRG) and collaborates in post-graduate programs at national and international level on the field of biotechnology and health. He has a strong list of national and international collaborations in the areas of controlled drug delivery, nanomedicine and tissue engineering.

5. Development of new drug delivery systems using colloidal nanoparticles Therapeutic polymers for drug delivery Therapeutic polymers as new targeted cancer systems Methods of micro and nanoencapsulation of biotech drugs Biosimilars Physical and chemical characterization of pharmaceutical dosage forms (DSC, FTIR, CD, PCS, LDA, SEM, TEM, AFM, HPLC, UV) Structural characterization of proteins In vitro and in vivo models of drug bioavailability through gastrointestinal barrier Cell-culture models for drug absorption studies In vitro and in vivo models of drug bioavailability Biomaterials Cell-material interaction Advanced Light Microscopy and Flow Cytometry.

21. Bruno Sarmento, PhD INEB - Instituto de Engenharia Biomédica (www.ineb.up.pt) Universidade do Porto Rua do Campo Alegre, 823 - 4150-180 Porto, Portugal Phone: +351 226074900/82, Fax: +351 226094567 E-mail: bruno.sarmento@ineb.up.ptwww.ineb.up.ptbruno.sarmento@ineb.up.pt